<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7799333</article-id>
    <article-id pub-id-type="pmid">33346828</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btaa1057</article-id>
    <article-id pub-id-type="publisher-id">btaa1057</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Databases and Ontologies</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>The COVID-19 Ontology</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5860-6369</contrib-id>
        <name>
          <surname>Sargsyan</surname>
          <given-names>Astghik</given-names>
        </name>
        <aff><institution>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)</institution>, 53754 Sankt Augustin, <country country="DE">Germany</country></aff>
        <aff><institution>Bonn-Aachen International Center for Information Technology (B-IT), University of Bonn</institution>, 53113 Bonn, <country country="DE">Germany</country></aff>
        <xref rid="btaa1057-FM2" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kodamullil</surname>
          <given-names>Alpha Tom</given-names>
        </name>
        <aff><institution>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)</institution>, 53754 Sankt Augustin, <country country="DE">Germany</country></aff>
        <xref rid="btaa1057-FM2" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Baksi</surname>
          <given-names>Shounak</given-names>
        </name>
        <aff><institution>Causality Biomodels, Kinfra Hi-Tech Park</institution>, Cochin, Kerala 683503, <country country="IN">India</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Darms</surname>
          <given-names>Johannes</given-names>
        </name>
        <aff><institution>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)</institution>, 53754 Sankt Augustin, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Madan</surname>
          <given-names>Sumit</given-names>
        </name>
        <aff><institution>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)</institution>, 53754 Sankt Augustin, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gebel</surname>
          <given-names>Stephan</given-names>
        </name>
        <aff><institution>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)</institution>, 53754 Sankt Augustin, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Keminer</surname>
          <given-names>Oliver</given-names>
        </name>
        <aff><institution>Fraunhofer Institute for Molecular Biology and Applied Ecology-ScreeningPort</institution>, Hamburg, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jose</surname>
          <given-names>Geena Mariya</given-names>
        </name>
        <aff><institution>Causality Biomodels, Kinfra Hi-Tech Park</institution>, Cochin, Kerala 683503, <country country="IN">India</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Balabin</surname>
          <given-names>Helena</given-names>
        </name>
        <aff><institution>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)</institution>, 53754 Sankt Augustin, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>DeLong</surname>
          <given-names>Lauren Nicole</given-names>
        </name>
        <aff><institution>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)</institution>, 53754 Sankt Augustin, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kohler</surname>
          <given-names>Manfred</given-names>
        </name>
        <aff><institution>Fraunhofer Institute for Molecular Biology and Applied Ecology-ScreeningPort</institution>, Hamburg, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jacobs</surname>
          <given-names>Marc</given-names>
        </name>
        <aff><institution>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)</institution>, 53754 Sankt Augustin, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Hofmann-Apitius</surname>
          <given-names>Martin</given-names>
        </name>
        <xref rid="btaa1057-cor1" ref-type="corresp"/>
        <aff><institution>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI)</institution>, 53754 Sankt Augustin, <country country="DE">Germany</country></aff>
        <aff><institution>Bonn-Aachen International Center for Information Technology (B-IT), University of Bonn</institution>, 53113 Bonn, <country country="DE">Germany</country></aff>
        <!--alpha.tom.kodamullil@scai.fraunhofer.de-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Kelso</surname>
          <given-names>Janet</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <fn id="btaa1057-FM2">
        <p>The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.</p>
      </fn>
      <corresp id="btaa1057-cor1">To whom correspondence should be addressed. <email>alpha.tom.kodamullil@scai.fraunhofer.de</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>12</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2020-12-21">
      <day>21</day>
      <month>12</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>21</day>
      <month>12</month>
      <year>2020</year>
    </pub-date>
    <volume>36</volume>
    <issue>24</issue>
    <fpage>5703</fpage>
    <lpage>5705</lpage>
    <history>
      <date date-type="received">
        <day>22</day>
        <month>6</month>
        <year>2020</year>
      </date>
      <date date-type="rev-recd">
        <day>05</day>
        <month>11</month>
        <year>2020</year>
      </date>
      <date date-type="editorial-decision">
        <day>07</day>
        <month>12</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>09</day>
        <month>12</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2020. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btaa1057.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>The COVID-19 pandemic has prompted an impressive, worldwide response by the academic community. In order to support text mining approaches as well as data description, linking and harmonization in the context of COVID-19, we have developed an ontology representing major novel coronavirus (SARS-CoV-2) entities. The ontology has a strong scope on chemical entities suited for drug repurposing, as this is a major target of ongoing COVID-19 therapeutic development.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>The ontology comprises 2270 classes of concepts and 38 987 axioms (2622 logical axioms and 2434 declaration axioms). It depicts the roles of molecular and cellular entities in virus-host interactions and in the virus life cycle, as well as a wide spectrum of medical and epidemiological concepts linked to COVID-19. The performance of the ontology has been tested on Medline and the COVID-19 corpus provided by the Allen Institute.</p>
      </sec>
      <sec id="s3">
        <title>Availabilityand implementation</title>
        <p>COVID-19 Ontology is released under a Creative Commons 4.0 License and shared via <ext-link xlink:href="https://github.com/covid-19-ontology/covid-19" ext-link-type="uri">https://github.com/covid-19-ontology/covid-19</ext-link>. The ontology is also deposited in BioPortal at <ext-link xlink:href="https://bioportal.bioontology.org/ontologies/COVID-19" ext-link-type="uri">https://bioportal.bioontology.org/ontologies/COVID-19</ext-link>.</p>
      </sec>
      <sec id="s5">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>MAVO program</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Fraunhofer Society</institution>
            <institution-id institution-id-type="DOI">10.13039/501100003185</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Since the end of 2019, the COVID-19 pandemic is in the spotlight of the global scientific community. The spectrum of scientific approaches to combat SARS-CoV-2 includes diverse disciplines such as epidemiology modeling (<xref rid="btaa1057-B4" ref-type="bibr">Kucharski <italic toggle="yes">et al.</italic>, 2020</xref>, <xref rid="btaa1057-B7" ref-type="bibr">Zhao and Chen, 2020</xref>), molecular docking and molecular dynamics on supercomputers (<xref rid="btaa1057-B5" ref-type="bibr">Smith and Smith, 2020</xref>) and high throughput screening using drug-repurposing libraries (<xref rid="btaa1057-B3" ref-type="bibr">Jin <italic toggle="yes">et al.</italic>, 2020</xref>, <xref rid="btaa1057-B6" ref-type="bibr">Ton <italic toggle="yes">et al.</italic>, 2020</xref>).</p>
    <p>One major bottleneck facing current strategies to find candidate compounds for drug repurposing is the limited availability of chemical information in the COVID-19 context. Any serious attempt at identifying new or repurposed drugs against SARS-CoV-2 needs to consider what has been published on the respective drug target and what classes of chemical compounds display activity against viral proteins. Despite that, various publications claim to have identified new candidates for drug repurposing (<xref rid="btaa1057-B2" ref-type="bibr">Fan <italic toggle="yes">et al.</italic>, 2020</xref>). The literature on COVID-19 targets and putative target-binding ligands is growing with impressive dynamics.</p>
    <p>To facilitate dedicated literature searches on COVID-19 pathophysiology, epidemiology, targets and medical implications, we have generated a prototypical version of a COVID-19 ontology. This ontology is meant to capture and represent the majority of essential entities and concepts relevant for COVID-19 research context. The ontology serves two major purposes:
</p>
    <list list-type="alpha-lower">
      <list-item>
        <p>As a template to define context in COVID-19 specific text mining approaches.</p>
      </list-item>
      <list-item>
        <p>As a structured system of concepts and categories that helps to bring order into the COVID-19 knowledge space.</p>
      </list-item>
    </list>
    <p>We demonstrate the usability of the COVID-19 Ontology in both cases.</p>
  </sec>
  <sec>
    <title>2 Material and methods</title>
    <p>Starting from a mind map generated by a concerted action of biologists, pharmacologists and computational biologists working on COVID-19, we identified major aspects of virology, epidemiology, chemical biology and clinical aspects relevant for translational COVID-19 research. Extensive literature searches were done to enrich entities and concepts relevant for the disease. An expert-curated mind map of COVID-19 knowledge was used to establish the core structure of the ontology. Relevant entities and concepts were collected from 32 Research articles, 10 Reviews, as well as from various relevant websites such as WHO (<ext-link xlink:href="https://www.who.int/" ext-link-type="uri">https://www.who.int/</ext-link>), Radiology Assistant COVID-19 (<ext-link xlink:href="https://radiologyassistant.nl/chest/lk-jg-1" ext-link-type="uri">https://radiologyassistant.nl/chest/lk-jg-1</ext-link>), Centre for Evidence-Based Medicine (<ext-link xlink:href="https://www.cebm.net/covid-19/registered-trials-and-analysis" ext-link-type="uri">https://www.cebm.net/covid-19/registered-trials-and-analysis</ext-link>), Texas Medical Center (<ext-link xlink:href="https://www.tmc.edu/news/2020/03/covid-19-crisis-catalog-a-Glossary-of-terms" ext-link-type="uri">https://www.tmc.edu/news/2020/03/covid-19-crisis-catalog-a-Glossary-of-terms</ext-link>), Yale Medicine (<ext-link xlink:href="https://www.yalemedicine.org/stories/covid-19-glossary/" ext-link-type="uri">https://www.yalemedicine.org/stories/covid-19-glossary/</ext-link>), Targeting COVID-19: GHDDI Info Sharing Portal (<ext-link xlink:href="https://ghddi-ailab.github.io/Targeting2019-nCoV" ext-link-type="uri">https://ghddi-ailab.github.io/Targeting2019-nCoV</ext-link>), Summit Medical Group (<ext-link xlink:href="https://www.summitmedicalgroup.com/news/living-well/must-know-Covid-19-vocabulary" ext-link-type="uri">https://www.summitmedicalgroup.com/news/living-well/must-know-Covid-19-vocabulary</ext-link>) and Georgetown University (<ext-link xlink:href="https://www.georgetown.edu/Coronavirus/glossary-of-terms" ext-link-type="uri">https://www.georgetown.edu/Coronavirus/glossary-of-terms</ext-link>). Additionally, we have also included some of the openly available vocabularies, e.g. (<ext-link xlink:href="https://github.com/SciBiteLabs/CORD19/" ext-link-type="uri">https://github.com/SciBiteLabs/CORD19/</ext-link>) as well as a manually curated version of n-grams (bi- and trigrams), representing a list of terms co-occurring most frequently, generated using 2170 abstracts from the LitCovid database as of April 1, 2020 (see Supplementary Document).</p>
    <p>The COVID-19 Ontology was assembled using the Protégé ontology editor. This ontology is constructed based on guidelines and principles defined by Open Biological and Biomedical Ontology (OBO, <ext-link xlink:href="http://www.obofoundry.org/" ext-link-type="uri">http://www.obofoundry.org/</ext-link>) foundry as well as aligned with the Basic Formal Ontology (BFO) hierarchy. We applied Ontofox (<ext-link xlink:href="http://ontofox.hegroup.org" ext-link-type="uri">http://ontofox.hegroup.org</ext-link>) to reuse already existing classes from other relevant ontologies. Terms not predefined in other ontologies are added with proper definitions as well as clear provenance. In order to increase recall in text mining applications, we have added synonyms for each concept. The COVID-19 Ontology is released under a Creative Commons 4.0 License and shared via <ext-link xlink:href="https://github.com/covid-19-ontology/covid-19" ext-link-type="uri">https://github.com/covid-19-ontology/covid-19</ext-link>. The ontology is also deposited in BioPortal at <ext-link xlink:href="https://bioportal.bioontology.org/ontologies/COVID-19" ext-link-type="uri">https://bioportal.bioontology.org/ontologies/COVID-19</ext-link> and in the COVID-OLS at <ext-link xlink:href="https://ols-covid.scaiview.com/ols/ontologies/covid19" ext-link-type="uri">https://ols-covid.scaiview.com/ols/ontologies/covid19</ext-link>. The version made available here will be constantly updated. We would like to encourage the community to help us improve the ontology by providing feedback and application examples.</p>
  </sec>
  <sec>
    <title>3 Results</title>
    <p>The COVID-19 Ontology comprises 2270 terms, including 2121 terms imported from existing ontologies together with 149 newly defined terms. The ontology focuses on a wide spectrum of domain-specific topics ranging from epidemiology (risk factors, transmission, etc.), via clinical aspects (such as signs and symptoms, diagnostics, medical intervention) and aspects of prevention and control, to clinical trials, genetic and molecular processes (of both human and virus) and signaling pathways.</p>
    <p>We are aware of the parallel development of ontologies (see Supplementary Document for comparison with other related ontologies) around COVID-19, however, many of them were not suitable for the use cases we define below.</p>
    <sec>
      <title>3.1 Application in text mining</title>
      <p>From the COVID-19 Ontology, we have derived a terminology tailored for use in text mining. For named entity recognition, concepts and entities were used together with their synonyms. The terminology was then integrated into the literature mining engine SCAIView (<ext-link xlink:href="https://covid.scaiview.com/" ext-link-type="uri">https://covid.scaiview.com/</ext-link>) and tested in retrieval and entity recognition experiments. Adaptation of the ontology for text mining purposes allows for information retrieval and information extraction of COVID-related research topics such as ‘risk factor’, ‘clinical aspect’, ‘prevention and control’, ‘model’, ‘transmission process’, ‘signs and symptoms’, ’virology’. The aforementioned topics are defined via logical Axioms. This allows grouping of related concepts and classes. This is used in the search engine SCAIView to aggregate related research documents into topics (see Supplementary Document). The text mining service will be made publicly available in a dedicated, public SCAIView COVID environment.</p>
    </sec>
    <sec>
      <title>3.2 Organizing the COVID-19 knowledge space</title>
      <p>The ontology is used to annotate data and models in the COVID-19 Knowledge Space (<ext-link xlink:href="https://www.covid19-knowledgespace.de" ext-link-type="uri">https://www.covid19-knowledgespace.de</ext-link>). We are using the COVID-19 ontology for efficient data interchange, data sharing and semantic interoperability among different sources in the COVID-19 Knowledge Space. One of the core components of the COVID-19 Knowledge Space is the Covid Knowledge SuperGraph (<ext-link xlink:href="https://www.covid19-knowledgespace.de/" ext-link-type="uri">https://www.covid19-knowledgespace.de/</ext-link>), which is built by integrating knowledge from literature, publicly available knowledge graphs and disease maps including proprietary pathophysiology graphs (<ext-link xlink:href="https://precisionlife.com/news/Covid19-sepsis/" ext-link-type="uri">https://precisionlife.com/news/Covid19-sepsis/</ext-link>). COVID-19 Ontology is used to attain the semantic interoperability and mapping between various entities and relationships in the COVID Knowledge SuperGraph.</p>
    </sec>
  </sec>
  <sec>
    <title>4 Discussion</title>
    <p>The novel coronavirus has been the prime focus of thousands of scientific research topics for almost several months. Numerous scientific publications are published, and dealing with that much information brings growing limitations for the researchers and clinicians, and it is crucial to implement tools to overcome the mentioned issue. The developed COVID-19 Ontology captures and represents the essential entities and concepts relevant for COVID-19 research, and is meant to assist text mining approaches and semantic interoperability in the COVID-19 domain. COVID-19 Ontology mentioned here forms the basis for establishing the reference namespace for the COVID Knowledge Graph that encapsulates the molecular mechanisms around COVID-19 infection (Domingo-Fernández <italic toggle="yes">et al.</italic>, 2020). With the text mining use case described in our paper, researchers and clinicians have the opportunity to find papers more specific to their interests. It is also noteworthy to mention that our ontology is well suited to categorize and annotate the rapidly growing number of COVID-19 portals.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btaa1057_Supplementary_Data</label>
      <media xlink:href="btaa1057_supplementary_data.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors thank Thrishna KG, Abish K, Priya S from Causality Biomodels for the ontology curation work.</p>
    <sec>
      <title>Funding</title>
      <p>This work was supported by the MAVO program of the Fraunhofer Society.</p>
    </sec>
    <sec sec-type="COI-statement">
      <title>Conflict of Interest</title>
      <p>none declared.</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btaa1057-B1">
      <mixed-citation publication-type="other">Domingo-Fernández. <etal>et al</etal> (<year>2020</year>) COVID-19 Knowledge Graph: a computable, multi-modal, cause-and-effect knowledge model of COVID-19 pathophysiology, <italic toggle="yes">Bioinformatics</italic>, btaa834, https://doi.org/10.1093/bioinformatics/btaa834</mixed-citation>
    </ref>
    <ref id="btaa1057-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fan</surname><given-names>H.H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) 
<article-title>Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus (2019-nCoV) related coronavirus model</article-title>. <source>Chin. Med. J. (Engl.)</source>.</mixed-citation>
    </ref>
    <ref id="btaa1057-B3">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Jin</surname><given-names>Z.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19 bioRxiv. doi:10.1101/2020.02.26.964882.</mixed-citation>
    </ref>
    <ref id="btaa1057-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kucharski</surname><given-names>A.J.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) 
<article-title>Early dynamics of transmission and control of COVID-19: a mathematical modelling studyLancet</article-title>. <source>Infect Dis</source>. doi: 10.1016/S1473-3099(20)30144-4</mixed-citation>
    </ref>
    <ref id="btaa1057-B5">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>M.</given-names></string-name>, <string-name><surname>Smith</surname><given-names>J.C.</given-names></string-name></person-group> (<year>2020</year>) Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface. ChemRxiv. doi:10.26434/chemrxiv.11871402.v4</mixed-citation>
    </ref>
    <ref id="btaa1057-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ton</surname><given-names>A.T.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) 
<article-title>2020 rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds</article-title>. <source>Mol. Inform</source>., <volume>39</volume>, <fpage>2000028</fpage>.<pub-id pub-id-type="pmid">32162456</pub-id></mixed-citation>
    </ref>
    <ref id="btaa1057-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>H.</given-names></string-name></person-group> (<year>2020</year>) 
<article-title>Modeling the epidemic dynamics and control of COVID-19 outbreak in China</article-title>. <source>Quant. Biol</source>., <volume>8</volume>, <fpage>11</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">32219006</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
